-
1
-
-
1842855423
-
Incretins, insulin secretion and Type 2 diabetes mellitus
-
Vilsboll, T. and Holst, J. J. (2004) Incretins, insulin secretion and Type 2 diabetes mellitus Diabetologia 47, 357-366
-
(2004)
Diabetologia
, vol.47
, pp. 357
-
-
Vilsboll, T.1
Holst, J.J.2
-
2
-
-
0026648961
-
Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas
-
Eng, J., Kleinman, W. A., Singh, L., Singh, G., and Raufman, J. P. (1992) Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas J. Biol. Chem. 267, 7402-7405
-
(1992)
J. Biol. Chem.
, vol.267
, pp. 7402
-
-
Eng, J.1
Kleinman, W.A.2
Singh, L.3
Singh, G.4
Raufman, J.P.5
-
3
-
-
0035818410
-
Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states
-
Neidigh, J. W., Fesinmeyer, R. M., Prickett, K. S., and Andersen, N. H. (2001) Exendin-4 and glucagon-like-peptide-1: NMR structural comparisons in the solution and micelle-associated states Biochemistry 40, 13188-13200
-
(2001)
Biochemistry
, vol.40
, pp. 13188
-
-
Neidigh, J.W.1
Fesinmeyer, R.M.2
Prickett, K.S.3
Andersen, N.H.4
-
4
-
-
0028207562
-
Structure of glucagon-like peptide (7-36) amide in a dodecylphosphocholine micelle as determined by 2D NMR
-
Thornton, K. and Gorenstein, D. G. (1994) Structure of glucagon-like peptide (7-36) amide in a dodecylphosphocholine micelle as determined by 2D NMR Biochemistry 33, 3532-3539
-
(1994)
Biochemistry
, vol.33
, pp. 3532
-
-
Thornton, K.1
Gorenstein, D.G.2
-
5
-
-
0027184119
-
Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells
-
Goke, R., Fehmann, H. C., Linn, T., Schmidt, H., Krause, M., Eng, J., and Goke, B. (1993) Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells J. Biol. Chem. 268, 19650-19655
-
(1993)
J. Biol. Chem.
, vol.268
, pp. 19650
-
-
Goke, R.1
Fehmann, H.C.2
Linn, T.3
Schmidt, H.4
Krause, M.5
Eng, J.6
Goke, B.7
-
6
-
-
0028171996
-
Exendin-4 and exendin-(9-39)NH2: Agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2
-
Schepp, W., Schmidtler, J., Riedel, T., Dehne, K., Schusdziarra, V., Holst, J. J., Eng, J., Raufman, J. P., and Classen, M. (1994) Exendin-4 and exendin-(9-39)NH2: agonist and antagonist, respectively, at the rat parietal cell receptor for glucagon-like peptide-1-(7-36)NH2 Eur. J. Pharmacol. 269, 183-191
-
(1994)
Eur. J. Pharmacol.
, vol.269
, pp. 183
-
-
Schepp, W.1
Schmidtler, J.2
Riedel, T.3
Dehne, K.4
Schusdziarra, V.5
Holst, J.J.6
Eng, J.7
Raufman, J.P.8
Classen, M.9
-
7
-
-
0030779816
-
High potency antagonists of the pancreatic glucagon-like peptide-1 receptor
-
Montrose-Rafizadeh, C., Yang, H., Rodgers, B. D., Beday, A., Pritchette, L. A., and Eng, J. (1997) High potency antagonists of the pancreatic glucagon-like peptide-1 receptor J. Biol. Chem. 272, 21201-21206
-
(1997)
J. Biol. Chem.
, vol.272
, pp. 21201
-
-
Montrose-Rafizadeh, C.1
Yang, H.2
Rodgers, B.D.3
Beday, A.4
Pritchette, L.A.5
Eng, J.6
-
8
-
-
0029958404
-
Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene
-
Scrocchi, L. A., Brown, T. J., MaClusky, N., Brubaker, P. L., Auerbach, A. B., Joyner, A. L., and Drucker, D. J. (1996) Glucose intolerance but normal satiety in mice with a null mutation in the glucagon-like peptide 1 receptor gene Nat. Med. 2, 1254-1258
-
(1996)
Nat. Med.
, vol.2
, pp. 1254
-
-
Scrocchi, L.A.1
Brown, T.J.2
MacLusky, N.3
Brubaker, P.L.4
Auerbach, A.B.5
Joyner, A.L.6
Drucker, D.J.7
-
9
-
-
72449157026
-
Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas
-
Nachnani, J. S., Bulchandani, D. G., Nookala, A., Herndon, B., Molteni, A., Pandya, P., Taylor, R., Quinn, T., Weide, L., and Alba, L. M. (2010) Biochemical and histological effects of exendin-4 (exenatide) on the rat pancreas Diabetologia 53, 153-159
-
(2010)
Diabetologia
, vol.53
, pp. 153
-
-
Nachnani, J.S.1
Bulchandani, D.G.2
Nookala, A.3
Herndon, B.4
Molteni, A.5
Pandya, P.6
Taylor, R.7
Quinn, T.8
Weide, L.9
Alba, L.M.10
-
10
-
-
33748319404
-
Lymphocytic infiltration and immune activation in metallothionein promoter-exendin-4 (MT-Exendin) transgenic mice
-
Baggio, L. L., Holland, D., Wither, J., and Drucker, D. J. (2006) Lymphocytic infiltration and immune activation in metallothionein promoter-exendin-4 (MT-Exendin) transgenic mice Diabetes 55, 1562-1570
-
(2006)
Diabetes
, vol.55
, pp. 1562
-
-
Baggio, L.L.1
Holland, D.2
Wither, J.3
Drucker, D.J.4
-
11
-
-
54449098531
-
Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion
-
De Leon, D. D., Li, C., Delson, M. I., Matschinsky, F. M., Stanley, C. A., and Stoffers, D. A. (2008) Exendin-(9-39) corrects fasting hypoglycemia in SUR-1-/- mice by lowering cAMP in pancreatic beta-cells and inhibiting insulin secretion J. Biol. Chem. 283, 25786-25793
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 25786
-
-
De Leon, D.D.1
Li, C.2
Delson, M.I.3
Matschinsky, F.M.4
Stanley, C.A.5
Stoffers, D.A.6
-
12
-
-
27744539718
-
Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: Evidence for inappropriate insulin secretion and pancreatic islet hyperplasia
-
Patti, M. E., McMahon, G., Mun, E. C., Bitton, A., Holst, J. J., Goldsmith, J., Hanto, D. W., Callery, M., Arky, R., Nose, V., Bonner-Weir, S., and Goldfine, A. B. (2005) Severe hypoglycaemia post-gastric bypass requiring partial pancreatectomy: evidence for inappropriate insulin secretion and pancreatic islet hyperplasia Diabetologia 48, 2236-2240
-
(2005)
Diabetologia
, vol.48
, pp. 2236
-
-
Patti, M.E.1
McMahon, G.2
Mun, E.C.3
Bitton, A.4
Holst, J.J.5
Goldsmith, J.6
Hanto, D.W.7
Callery, M.8
Arky, R.9
Nose, V.10
Bonner-Weir, S.11
Goldfine, A.B.12
-
13
-
-
18844412634
-
Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice
-
Green, B. D., Irwin, N., Gault, V. A., Bailey, C. J., O'Harte, F. P., and Flatt, P. R. (2005) Chronic treatment with exendin(9-39)amide indicates a minor role for endogenous glucagon-like peptide-1 in metabolic abnormalities of obesity-related diabetes in ob/ob mice J. Endocrinol. 185, 307-317
-
(2005)
J. Endocrinol.
, vol.185
, pp. 307
-
-
Green, B.D.1
Irwin, N.2
Gault, V.A.3
Bailey, C.J.4
O'Harte, F.P.5
Flatt, P.R.6
-
14
-
-
58149330670
-
Mary, Mary, quite contrary, how do your beta-cells fail
-
2564
-
Leahy, J. L. (2008) Mary, Mary, quite contrary, how do your beta-cells fail Diabetes 57, 2563-2564
-
(2008)
Diabetes
, vol.57
, pp. 2563
-
-
Leahy, J.L.1
-
15
-
-
45549086826
-
Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain
-
Runge, S., Thogersen, H., Madsen, K., Lau, J., and Rudolph, R. (2008) Crystal structure of the ligand-bound glucagon-like peptide-1 receptor extracellular domain J. Biol. Chem. 283, 11340-11347
-
(2008)
J. Biol. Chem.
, vol.283
, pp. 11340
-
-
Runge, S.1
Thogersen, H.2
Madsen, K.3
Lau, J.4
Rudolph, R.5
-
16
-
-
73649107900
-
Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor
-
Underwood, C. R., Garibay, P., Knudsen, L. B., Hastrup, S., Peters, G. H., Rudolph, R., and Reedtz-Runge, S. (2010) Crystal structure of glucagon-like peptide-1 in complex with the extracellular domain of the glucagon-like peptide-1 receptor J. Biol. Chem. 285, 723-730
-
(2010)
J. Biol. Chem.
, vol.285
, pp. 723
-
-
Underwood, C.R.1
Garibay, P.2
Knudsen, L.B.3
Hastrup, S.4
Peters, G.H.5
Rudolph, R.6
Reedtz-Runge, S.7
-
17
-
-
56949096744
-
Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists
-
Lin, F. and Wang, R. (2009) Molecular modeling of the three-dimensional structure of GLP-1R and its interactions with several agonists J. Mol. Model. 15, 53-65
-
(2009)
J. Mol. Model.
, vol.15
, pp. 53
-
-
Lin, F.1
Wang, R.2
-
18
-
-
70349308687
-
A new glucagon and GLP-1 co-agonist eliminates obesity in rodents
-
Day, J. W., Ottaway, N., Patterson, J. T., Gelfanov, V., Smiley, D., Gidda, J., Findeisen, H., Bruemmer, D., Drucker, D. J., Chaudhary, N., Holland, J., Hembree, J., Abplanalp, W., Grant, E., Ruehl, J., Wilson, H., Kirchner, H., Lockie, S. H., Hofmann, S., Woods, S. C., Nogueiras, R., Pfluger, P. T., Perez-Tilve, D., DiMarchi, R., and Tschop, M. H. (2009) A new glucagon and GLP-1 co-agonist eliminates obesity in rodents Nat. Chem. Biol. 5, 749-757
-
(2009)
Nat. Chem. Biol.
, vol.5
, pp. 749
-
-
Day, J.W.1
Ottaway, N.2
Patterson, J.T.3
Gelfanov, V.4
Smiley, D.5
Gidda, J.6
Findeisen, H.7
Bruemmer, D.8
Drucker, D.J.9
Chaudhary, N.10
Holland, J.11
Hembree, J.12
Abplanalp, W.13
Grant, E.14
Ruehl, J.15
Wilson, H.16
Kirchner, H.17
Lockie, S.H.18
Hofmann, S.19
Woods, S.C.20
Nogueiras, R.21
Pfluger, P.T.22
Perez-Tilve, D.23
Dimarchi, R.24
Tschop, M.H.25
more..
-
19
-
-
0037349103
-
Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity
-
Runge, S., Wulff, B. S., Madsen, K., Brauner-Osborne, H., and Knudsen, L. B. (2003) Different domains of the glucagon and glucagon-like peptide-1 receptors provide the critical determinants of ligand selectivity Br. J. Pharmacol. 138, 787-794
-
(2003)
Br. J. Pharmacol.
, vol.138
, pp. 787
-
-
Runge, S.1
Wulff, B.S.2
Madsen, K.3
Brauner-Osborne, H.4
Knudsen, L.B.5
-
20
-
-
34248563781
-
Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain
-
Runge, S., Schimmer, S., Oschmann, J., Schiodt, C. B., Knudsen, S. M., Jeppesen, C. B., Madsen, K., Lau, J., Thogersen, H., and Rudolph, R. (2007) Differential structural properties of GLP-1 and exendin-4 determine their relative affinity for the GLP-1 receptor N-terminal extracellular domain Biochemistry 46, 5830-5840
-
(2007)
Biochemistry
, vol.46
, pp. 5830
-
-
Runge, S.1
Schimmer, S.2
Oschmann, J.3
Schiodt, C.B.4
Knudsen, S.M.5
Jeppesen, C.B.6
Madsen, K.7
Lau, J.8
Thogersen, H.9
Rudolph, R.10
-
21
-
-
0037518197
-
The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1
-
Lopez de Maturana, R., Willshaw, A., Kuntzsch, A., Rudolph, R., and Donnelly, D. (2003) The isolated N-terminal domain of the glucagon-like peptide-1 (GLP-1) receptor binds exendin peptides with much higher affinity than GLP-1 J. Biol. Chem. 278, 10195-10200
-
(2003)
J. Biol. Chem.
, vol.278
, pp. 10195
-
-
Lopez De Maturana, R.1
Willshaw, A.2
Kuntzsch, A.3
Rudolph, R.4
Donnelly, D.5
-
22
-
-
0030602177
-
The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity
-
Wilmen, A., Goke, B., and Goke, R. (1996) The isolated N-terminal extracellular domain of the glucagon-like peptide-1 (GLP)-1 receptor has intrinsic binding activity FEBS Lett. 398, 43-47
-
(1996)
FEBS Lett.
, vol.398
, pp. 43
-
-
Wilmen, A.1
Goke, B.2
Goke, R.3
-
23
-
-
0030607672
-
Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor
-
Knudsen, L. B. and Pridal, L. (1996) Glucagon-like peptide-1-(9-36) amide is a major metabolite of glucagon-like peptide-1-(7-36) amide after in vivo administration to dogs, and it acts as an antagonist on the pancreatic receptor Eur. J. Pharmacol. 318, 429-435
-
(1996)
Eur. J. Pharmacol.
, vol.318
, pp. 429
-
-
Knudsen, L.B.1
Pridal, L.2
-
24
-
-
0038359686
-
Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1-(9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans
-
Vahl, T. P., Paty, B. W., Fuller, B. D., Prigeon, R. L., and D'Alessio, D. A. (2003) Effects of GLP-1-(7-36)NH2, GLP-1-(7-37), and GLP-1-(9-36)NH2 on intravenous glucose tolerance and glucose-induced insulin secretion in healthy humans J. Clin. Endocrinol. Metab. 88, 1772-1779
-
(2003)
J. Clin. Endocrinol. Metab.
, vol.88
, pp. 1772
-
-
Vahl, T.P.1
Paty, B.W.2
Fuller, B.D.3
Prigeon, R.L.4
D'Alessio, D.A.5
-
25
-
-
37849026464
-
Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: Importance of fatty acid length, polarity, and bulkiness
-
Madsen, K., Knudsen, L. B., Agersoe, H., Nielsen, P. F., Thogersen, H., Wilken, M., and Johansen, N. L. (2007) Structure-activity and protraction relationship of long-acting glucagon-like peptide-1 derivatives: importance of fatty acid length, polarity, and bulkiness J. Med. Chem. 50, 6126-6132
-
(2007)
J. Med. Chem.
, vol.50
, pp. 6126
-
-
Madsen, K.1
Knudsen, L.B.2
Agersoe, H.3
Nielsen, P.F.4
Thogersen, H.5
Wilken, M.6
Johansen, N.L.7
-
26
-
-
0037299115
-
Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: Evidence that GIP is the major physiological incretin
-
Gault, V. A., O'Harte, F. P., Harriott, P., Mooney, M. H., Green, B. D., and Flatt, P. R. (2003) Effects of the novel (Pro3)GIP antagonist and exendin(9-39)amide on GIP- and GLP-1-induced cyclic AMP generation, insulin secretion and postprandial insulin release in obese diabetic (ob/ob) mice: evidence that GIP is the major physiological incretin Diabetologia 46, 222-230
-
(2003)
Diabetologia
, vol.46
, pp. 222
-
-
Gault, V.A.1
O'Harte, F.P.2
Harriott, P.3
Mooney, M.H.4
Green, B.D.5
Flatt, P.R.6
-
27
-
-
0036132087
-
Medium-dependence of the secondary structure of exendin-4 and glucagon-like-peptide-1
-
Andersen, N. H., Brodsky, Y., Neidigh, J. W., and Prickett, K. S. (2002) Medium-dependence of the secondary structure of exendin-4 and glucagon-like-peptide-1 Bioorg. Med. Chem. 10, 79-85
-
(2002)
Bioorg. Med. Chem.
, vol.10
, pp. 79
-
-
Andersen, N.H.1
Brodsky, Y.2
Neidigh, J.W.3
Prickett, K.S.4
-
28
-
-
0028883257
-
Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide
-
Kolligs, F., Fehmann, H. C., Goke, R., and Goke, B. (1995) Reduction of the incretin effect in rats by the glucagon-like peptide 1 receptor antagonist exendin (9-39) amide Diabetes 44, 16-19
-
(1995)
Diabetes
, vol.44
, pp. 16
-
-
Kolligs, F.1
Fehmann, H.C.2
Goke, R.3
Goke, B.4
-
29
-
-
0036068322
-
Inhibition of gastric inhibitory polypeptide signaling prevents obesity
-
Miyawaki, K., Yamada, Y., Ban, N., Ihara, Y., Tsukiyama, K., Zhou, H., Fujimoto, S., Oku, A., Tsuda, K., Toyokuni, S., Hiai, H., Mizunoya, W., Fushiki, T., Holst, J. J., Makino, M., Tashita, A., Kobara, Y., Tsubamoto, Y., Jinnouchi, T., Jomori, T., and Seino, Y. (2002) Inhibition of gastric inhibitory polypeptide signaling prevents obesity Nat. Med. 8, 738-742
-
(2002)
Nat. Med.
, vol.8
, pp. 738
-
-
Miyawaki, K.1
Yamada, Y.2
Ban, N.3
Ihara, Y.4
Tsukiyama, K.5
Zhou, H.6
Fujimoto, S.7
Oku, A.8
Tsuda, K.9
Toyokuni, S.10
Hiai, H.11
Mizunoya, W.12
Fushiki, T.13
Holst, J.J.14
Makino, M.15
Tashita, A.16
Kobara, Y.17
Tsubamoto, Y.18
Jinnouchi, T.19
Jomori, T.20
Seino, Y.21
more..
-
30
-
-
0028821658
-
Glucagon-like peptide-1 is a physiological incretin in rat
-
Wang, Z., Wang, R. M., Owji, A. A., Smith, D. M., Ghatei, M. A., and Bloom, S. R. (1995) Glucagon-like peptide-1 is a physiological incretin in rat J. Clin. Invest. 95, 417-421
-
(1995)
J. Clin. Invest.
, vol.95
, pp. 417
-
-
Wang, Z.1
Wang, R.M.2
Owji, A.A.3
Smith, D.M.4
Ghatei, M.A.5
Bloom, S.R.6
-
31
-
-
0000385121
-
Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans
-
Schirra, J., Sturm, K., Leicht, P., Arnold, R., Goke, B., and Katschinski, M. (1998) Exendin(9-39)amide is an antagonist of glucagon-like peptide-1(7-36)amide in humans J. Clin. Invest. 101, 1421-1430
-
(1998)
J. Clin. Invest.
, vol.101
, pp. 1421
-
-
Schirra, J.1
Sturm, K.2
Leicht, P.3
Arnold, R.4
Goke, B.5
Katschinski, M.6
-
32
-
-
0032940582
-
Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat
-
Meeran, K., O'Shea, D., Edwards, C. M., Turton, M. D., Heath, M. M., Gunn, I., Abusnana, S., Rossi, M., Small, C. J., Goldstone, A. P., Taylor, G. M., Sunter, D., Steere, J., Choi, S. J., Ghatei, M. A., and Bloom, S. R. (1999) Repeated intracerebroventricular administration of glucagon-like peptide-1-(7-36) amide or exendin-(9-39) alters body weight in the rat Endocrinology 140, 244-250
-
(1999)
Endocrinology
, vol.140
, pp. 244
-
-
Meeran, K.1
O'Shea, D.2
Edwards, C.M.3
Turton, M.D.4
Heath, M.M.5
Gunn, I.6
Abusnana, S.7
Rossi, M.8
Small, C.J.9
Goldstone, A.P.10
Taylor, G.M.11
Sunter, D.12
Steere, J.13
Choi, S.J.14
Ghatei, M.A.15
Bloom, S.R.16
-
33
-
-
65949097938
-
Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity
-
Nogueiras, R., Perez-Tilve, D., Veyrat-Durebex, C., Morgan, D. A., Varela, L., Haynes, W. G., Patterson, J. T., Disse, E., Pfluger, P. T., Lopez, M., Woods, S. C., DiMarchi, R., Dieguez, C., Rahmouni, K., Rohner-Jeanrenaud, F., and Tschop, M. H. (2009) Direct control of peripheral lipid deposition by CNS GLP-1 receptor signaling is mediated by the sympathetic nervous system and blunted in diet-induced obesity J. Neurosci. 29, 5916-5925
-
(2009)
J. Neurosci.
, vol.29
, pp. 5916
-
-
Nogueiras, R.1
Perez-Tilve, D.2
Veyrat-Durebex, C.3
Morgan, D.A.4
Varela, L.5
Haynes, W.G.6
Patterson, J.T.7
Disse, E.8
Pfluger, P.T.9
Lopez, M.10
Woods, S.C.11
Dimarchi, R.12
Dieguez, C.13
Rahmouni, K.14
Rohner-Jeanrenaud, F.15
Tschop, M.H.16
-
34
-
-
42949175115
-
Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity
-
Miranda, L. P., Winters, K. A., Gegg, C. V., Patel, A., Aral, J., Long, J., Zhang, J., Diamond, S., Guido, M., Stanislaus, S., Ma, M., Li, H., Rose, M. J., Poppe, L., and Veniant, M. M. (2008) Design and synthesis of conformationally constrained glucagon-like peptide-1 derivatives with increased plasma stability and prolonged in vivo activity J. Med. Chem. 51, 2758-2765
-
(2008)
J. Med. Chem.
, vol.51
, pp. 2758
-
-
Miranda, L.P.1
Winters, K.A.2
Gegg, C.V.3
Patel, A.4
Aral, J.5
Long, J.6
Zhang, J.7
Diamond, S.8
Guido, M.9
Stanislaus, S.10
Ma, M.11
Li, H.12
Rose, M.J.13
Poppe, L.14
Veniant, M.M.15
-
35
-
-
79751495037
-
Charge inversion at position 68 of the glucagon and glucagon-like peptide-1 receptors supports selectivity in hormone action
-
In press.
-
Day, J. W., Li, P., Patterson, J. T., Chabenne, J., DiMarchi Chabenne, M., Gelfanov, V., and DiMarchi, R. Charge inversion at position 68 of the glucagon and glucagon-like peptide-1 receptors supports selectivity in hormone action, J. Pept. Sci. In press.
-
J. Pept. Sci.
-
-
Day, J.W.1
Li, P.2
Patterson, J.T.3
Chabenne, J.4
Dimarchi Chabenne, M.5
Gelfanov, V.6
Dimarchi, R.7
-
36
-
-
0026486811
-
In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences
-
Schnolzer, M., Alewood, P., Jones, A., Alewood, D., and Kent, S. B. (1992) In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences Int. J. Pept. Protein Res. 40, 180-193
-
(1992)
Int. J. Pept. Protein Res.
, vol.40
, pp. 180
-
-
Schnolzer, M.1
Alewood, P.2
Jones, A.3
Alewood, D.4
Kent, S.B.5
-
37
-
-
1542470485
-
Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis
-
Taicher, G. Z., Tinsley, F. C., Reiderman, A., and Heiman, M. L. (2003) Quantitative magnetic resonance (QMR) method for bone and whole-body-composition analysis Anal. Bioanal. Chem. 377, 990-1002
-
(2003)
Anal. Bioanal. Chem.
, vol.377
, pp. 990
-
-
Taicher, G.Z.1
Tinsley, F.C.2
Reiderman, A.3
Heiman, M.L.4
|